{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T13:14:03Z","timestamp":1782306843346,"version":"3.54.5"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T00:00:00Z","timestamp":1621814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>CDC6 (Cell division control protein 6), located at chromosome 17q21.3, plays an important role in the early stage of DNA replication and has unique functions in various malignant tumors. Here, we evaluate the relationship between CDC6 expression and oncology outcomes in patients with clear cell renal cell carcinoma (ccRCC).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective analysis of 118 ccRCC patients in Affiliated Hospital of Nantong University from 2015 to 2017 was performed. Triplicate tissue microarrays (TMA) were prepared from formalin-fixed and paraffin-embedded specimens. Immunohistochemistry (IHC) was conducted to evaluate the relationship between CDC6 expression and standard pathological features and prognosis. The RNA sequencing data and corresponding clinical information were acquired from the TCGA database. GSEA was used to identify signal pathways related to CDC6. Cox regression analysis was used to assess independent prognostic factors. In addition, the relationship between CDC6 and immunity was also investigated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The results of Kaplan\u2013Meier curve indicated that the OS of the patients with high expression of CDC6 was shorter than that of the patients with low CDC6 expression. Integrating the TCGA database and IHC staining, the results showed that CDC6 in ccRCC tissue was obviously up-regulated compared with adjacent normal kidney tissue. The results of Logistic regression analysis demonstrated that ccRCC patients with high expression of CDC6 are more likely to develop advanced disease than ccRCC patients with low CDC6 expression. The results of GSEA showed that the high expression of CDC6 was related to multiple signaling pathways. As for immunity, it was also related to TMB, immune checkpoint molecules, tumor microenvironment and immune infiltration. There were significantly correlations with CDC6 and immune cell infiltration levels and tumor microenvironment. The results of further results of the TCGA database showed that CDC6 was obviously related to immune checkpoint molecules and immune cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Increased expression of CDC6 is a potentially prognostic factor of poor prognosis in ccRCC patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2021.666418","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T06:48:36Z","timestamp":1621838916000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma"],"prefix":"10.3389","volume":"11","author":[{"given":"Yicong","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denglong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA: A Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyz136","article-title":"The Long-Term Rapid Increase in Incidence of Adenocarcinoma of the Kidney in the USA, Especially Among Younger Ages","volume":"48","author":"Zheng","year":"2019","journal-title":"Int J Epidemiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part a: Renal, Penile, and Testicular Tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-1354","article-title":"The Metabolic Basis of Kidney Cancer","volume":"9","author":"Linehan","year":"2019","journal-title":"Cancer Discovery"},{"key":"B5","doi-asserted-by":"publisher","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal Cell Carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"B6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.eururo.2014.04.029","article-title":"Understanding Pathologic Variants of Renal Cell Carcinoma: Distilling Therapeutic Opportunities From Biologic Complexity","volume":"67","author":"Shuch","year":"2015","journal-title":"Eur Urol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200305000-00005","article-title":"Comparisons of Outcome and Prognostic Features Among Histologic Subtypes of Renal Cell Carcinoma","volume":"27","author":"Cheville","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/jjco\/hyu216","article-title":"Five-Year Relative Survival Rate of Kidney and Renal Pelvis Cancer in the USA, Europe and Japan","volume":"45","author":"Matsuda","year":"2015","journal-title":"Japanese J Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.01.005","article-title":"Eau Guidelines on Renal Cell Carcinoma: 2014 Update","volume":"67","author":"Ljungberg","year":"2015","journal-title":"Eur Urol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2011.10885.x","article-title":"Cryoablation vs Radiofrequency Ablation for the Treatment of Renal Cell Carcinoma: A Meta-Analysis of Case Series Studies","volume":"110","author":"El Dib","year":"2012","journal-title":"BJU Int"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.02.001","article-title":"Five-Year Analysis of a Multi-Institutional Prospective Clinical Trial of Delayed Intervention and Surveillance for Small Renal Masses: The DISSRM Registry","volume":"68","author":"Pierorazio","year":"2015","journal-title":"Eur Urol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8737","article-title":"Increased B4GALT1 Expression Associates With Adverse Outcome in Patients With non-Metastatic Clear Cell Renal Cell Carcinoma","volume":"7","author":"Xie","year":"2016","journal-title":"Oncotarget"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3475","article-title":"Influence of Gene Expression on Survival of Clear Cell Renal Cell Carcinoma","volume":"9","author":"Berglund","year":"2020","journal-title":"Cancer Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000165693.68449.c3","article-title":"Renal Cell Carcinoma 2005: New Frontiers in Staging, Prognostication and Targeted Molecular Therapy","volume":"173","author":"Lam","year":"2005","journal-title":"J Urol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2008.04.056","article-title":"Update on the Medical Treatment of Metastatic Renal Cell Carcinoma","volume":"54","author":"Ravaud","year":"2008","journal-title":"Eur Urol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.763680","article-title":"The DNA Replication Protein Cdc6 Inhibits the Microtubule-Organizing Activity of the Centrosome","volume":"292","author":"Lee","year":"2017","journal-title":"J Biol Chem"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2014.1000182","article-title":"Spatio-Temporal Regulation of the Human Licensing Factor Cdc6 in Replication and Mitosis","volume":"14","author":"Kalfalah","year":"2015","journal-title":"Cell Cycle (Georgetown Tex.)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.178723","article-title":"Dna Replication Initiator Cdc6 Also Regulates Ribosomal DNA Transcription Initiation","volume":"129","author":"Huang","year":"2016","journal-title":"J Cell Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e23245","DOI":"10.1002\/jcla.23245","article-title":"A Pilot Study of Cdc6 as a Biomarker for Circulating Tumor Cells in Patients With Lung Cancer","volume":"34","author":"An","year":"2020","journal-title":"J Clin Lab Anal"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9897","article-title":"Whsc1l1 Drives Cell Cycle Progression Through Transcriptional Regulation of CDC6 and CDK2 in Squamous Cell Carcinoma of the Head and Neck","volume":"7","author":"Saloura","year":"2016","journal-title":"Oncotarget"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000000776","article-title":"Microrna-1297 Inhibits Proliferation and Promotes Apoptosis in Gastric Cancer Cells by Downregulating Cdc6 Expression","volume":"30","author":"Zhang","year":"2019","journal-title":"Anti-Cancer Drugs"},{"key":"B22","doi-asserted-by":"publisher","first-page":"498","DOI":"10.5114\/aoms.2018.73315","article-title":"Mir-26b Inhibits Growth and Resistance to Paclitaxel Chemotherapy by Silencing the CDC6 Gene in Gastric Cancer","volume":"15","author":"Zhao","year":"2019","journal-title":"Arch Med Sci AMS"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32900","article-title":"Cdc6 as a Novel Target in Cancer: Oncogenic Potential, Senescence and Subcellular Localisation","volume":"147","author":"Lim","year":"2020","journal-title":"Int J Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e303","DOI":"10.3346\/jkms.2018.33.e303","article-title":"Mrna Expression is Associated With the Aggressiveness of Prostate Cancer","volume":"33","author":"Kim","year":"2018","journal-title":"J Korean Med Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw1092","article-title":"Kegg: New Perspectives on Genomes, Pathways, Diseases and Drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e15661","DOI":"10.1371\/journal.pone.0015661","article-title":"Somatic Mutation Profiles of MSI and MSS Colorectal Cancer Identified by Whole Exome Next Generation Sequencing and Bioinformatics Analysis","volume":"5","author":"Timmermann","year":"2010","journal-title":"PloS One"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btx198","article-title":"Misa-Web: A Web Server for Microsatellite Prediction","volume":"33","author":"Beier","year":"2017","journal-title":"Bioinf (Oxford England)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 Human Cancer Genomes Reveals the Landscape of Tumor Mutational Burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13073-016-0264-5","article-title":"Pvac-Seq: A Genome-Guided in Silico Approach to Identifying Tumor Neoantigens","volume":"8","author":"Hundal","year":"2016","journal-title":"Genome Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring Tumour Purity and Stromal and Immune Cell Admixture From Expression Data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3337","article-title":"Robust Enumeration of Cell Subsets From Tissue Expression Profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"B32","doi-asserted-by":"publisher","first-page":"109228","DOI":"10.1016\/j.biopha.2019.109228","article-title":"Profiles of Immune Cell Infiltration and Immune-Related Genes in the Tumor Microenvironment of Colorectal Cancer","volume":"118","author":"Ge","year":"2019","journal-title":"Biomed Pharmacotherapy = Biomed Pharmacotherapie"}],"updated-by":[{"DOI":"10.3389\/fonc.2021.731942","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000}}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.666418\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T15:40:45Z","timestamp":1626882045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.666418\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,24]]},"references-count":32,"alternative-id":["10.3389\/fonc.2021.666418"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.666418","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fonc.2021.731942","asserted-by":"object"}]},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,24]]},"article-number":"666418"}}